Patents by Inventor Christopher Loren Vandeusen

Christopher Loren Vandeusen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chromene derivatives as inhibitors of TCR-Nck interaction
    Patent number: 11807633
    Abstract: The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: November 7, 2023
    Assignee: Artax Biopharma Inc.
    Inventors: Julio Castro, Andrés Gagete Mateos, Peter J. Machin, Christopher Loren Vandeusen
  • CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION
    Publication number: 20220081429
    Abstract: The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.
    Type: Application
    Filed: April 26, 2021
    Publication date: March 17, 2022
    Inventors: Julio CASTRO, Andrés GAGETE MATEOS, Peter J. MACHIN, Christopher Loren VANDEUSEN
  • Chromene derivatives as inhibitors of TCR-Nck interaction
    Patent number: 11008310
    Abstract: The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: May 18, 2021
    Assignee: Artax Biopharma Inc.
    Inventors: Julio Castro, Andrés Gagete Mateos, Peter J. Machin, Christopher Loren Vandeusen
  • CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION
    Publication number: 20200347042
    Abstract: The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 5, 2020
    Inventors: Julio CASTRO, Andrés GAGETE MATEOS, Peter J. MACHIN, Christopher Loren VANDEUSEN
  • Chromene derivatives as inhibitors of TCR-NCK interaction
    Patent number: 10696663
    Abstract: The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: June 30, 2020
    Assignee: Artax Biopharma Inc.
    Inventors: Julio Castro, Andrés Gagete Mateos, Peter J. Machin, Christopher Loren VanDeusen
  • CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION
    Publication number: 20190263792
    Abstract: The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.
    Type: Application
    Filed: February 27, 2019
    Publication date: August 29, 2019
    Inventors: Julio Castro, Andrés Gagete Mateos, Peter J. Machin, Christopher Loren VanDeusen
  • Pyrimidine hydrazide compounds as PGDS inhibitors
    Patent number: 8258130
    Abstract: This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: September 4, 2012
    Assignee: Sanofi
    Inventors: Suzanne C Aldous, Michael W Fennie, John Z Jiang, Stanly John, Lan Mu, Brian Pedgrift, James R Pribish, Barbara S Rauckman, Jeffrey S Sabol, Grzegorz T Stoklosa, Sukanthini Thurairatnam, Christopher Loren Vandeusen
  • Pyrimidine amide compounds as PGDS inhibitors
    Patent number: 8202863
    Abstract: This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: June 19, 2012
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Suzanne C. Aldous, John Ziqi Jiang, Jinqi Lu, Liang Ma, Lan Mu, Harry Randall Munson, Jeffrey Stephen Sabol, Sukanthini Thurairatnam, Christopher Loren Vandeusen
  • PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS
    Publication number: 20080227782
    Abstract: This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: April 4, 2008
    Publication date: September 18, 2008
    Applicant: AVENTIS PHARMACEUTICALS INC
    Inventors: Suzanne C. Aldous, John Ziqi Jiang, Jinqi Lu, Liang Ma, Lan Mu, Harry Randall Munson, Jeffrey Stephen Sabol, Sukanthini Thurairatnam, Christopher Loren Vandeusen